Navigation Links
Kitty Castellini Wins Roche Diabetes Care's Diabetes Heroes' Torchbearer Challenge
Date:12/2/2011

INDIANAPOLIS, Dec. 2, 2011 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce that Diabetes Living Today® Founder, President and CEO Kitty Castellini is the winner of Roche's inaugural Diabetes Heroes' Torchbearer Challenge.

Roche launched the online Diabetes Heroes program earlier this year to highlight and recognize historic and present-day individuals who have made important contributions to help others live full lives with diabetes. The site contains three groups: Trailblazers, Torchbearers and Everyday Heroes.

Trailblazers are scientists and researchers who have made important historic discoveries about how diabetes is diagnosed and treated. Torchbearers are present-day researchers, advocates and online community leaders who continue to blaze new trails in helping people with diabetes to live healthy, active lives. To increase the visibility of this very important group of modern-day heroes, Roche produced online video profiles of each Torchbearer and encouraged people to visit the site and "like" their favorite by Nov. 14, 2011, World Diabetes Day. Castellini received the most likes and as a result Roche will donate $10,000 in her name to the South Jersey JDRF Chapter.

"A diabetes hero is an ordinary person who finds the courage and strength to persevere and endure in spite of the overwhelming obstacles of diabetes," said Castellini.

The Diabetes Heroes site remains active and will continue to promote the incredible work being done by Kitty and her colleagues to assist people living with diabetes. Visitors to the Diabetes Heroes website may also add their own Everyday Hero by visiting the site and adding their own hero to the growing list.

For more information about Diabetes Living Today®, please visit http://diabeteslivingtoday.com. To learn more about the Diabetes Heroes website, please visit http://www.accu-chek.com/microsite/heroes/index.html

About Roche Diabetes Care

Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

About Kitty Castellini

Kitty Castellini, Founder, President and CEO of Diabetes Living Today®, has more than 47 years of experience with diabetes. Castellini is recognized as a national thought leader about diabetes by pharmaceutical companies, research institutes and those living with the disease. She is an active advocate for cure-focused research and fundraising. In 2007, the U.S. Congress acknowledged Castellini's impressive work in helping others who suffer from diabetes through her writing, fundraising and interviews. The State of New Jersey Senate honored her for her exemplary service, steadfast commitment and praiseworthy history of inspired leadership on behalf of her fellow citizens.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:

Todd Siesky 
Public Relations Manager
Roche Diabetes Care
Indianapolis, IN
(317) 521-3966 O
(317) 361-7637 C
todd.siesky@roche.com 

 


'/>"/>
SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. Electrochemistry controlled with a plasma electrode
4. Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing
5. Roche NimbleGen Announces New Pre-capture Multiplexing for Target Enrichment Technology in Sequencing
6. Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
7. Roche Submits Acute Hepatitis B Test to FDA for Premarket Approval
8. China Agri-Business Acquired Management and Operation Rights of Shaanxi Qinfeng Agrochemical Inc. in Xian, China
9. Proceedings of the National Academy of Sciences (PNAS) Publishes Roche Manuscript on Production of Bispecific IgG Antibodies
10. Roche Building Awarded LEED® Gold Certification
11. Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... The publishing ... Open Access publishing is one of the popular publication models that has received ... journals and 3000+ International Conferences across the globe, OMICS International ...
(Date:2/9/2016)... , Feb. 9, 2016 This market research ... current and future prospects of the market in terms ... include companies engaged in the manufacture of microbiology culture ... summary with a market snapshot providing the overall information ... this report. This section also provides the overall information ...
(Date:2/9/2016)... Feb. 9, 2016 BERG, a biopharmaceutical ... research approach, has announced the appointment of ... Chief Operating Officer. Haddock brings to BERG over ... 12 years in senior financial functions at pharmaceutical ... business organizational management. Niven R. ...
(Date:2/8/2016)... PLYMOUTH MEETING, Pa. , Feb. 8, 2016 /PRNewswire-USNewswire/ ... place of standard bone cement products to prevent infection ... a question that the experts at ECRI Institute have ... Cement: Fighting Infection or Fighting Your Bottom Line?" ... or Fighting Your Bottom Line?" --> ...
Breaking Biology Technology:
(Date:1/22/2016)... http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced the ... in Retail Sector 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ...
(Date:1/20/2016)... SAN JOSE, Calif. , Jan. 20, 2016 ... leading developer of human interface solutions, today announced ... touch controller solution for wearables and small screen ... appliances such as printers. Supporting round and rectangular ... the S1423 offers excellent performance with moisture on ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
Breaking Biology News(10 mins):